Does Wegovy work immediately, or does it take time to kick in?

What does happen in the first few weeks on Wegovy?

The very first pen delivers 0.25mg of semaglutide — a dose whose job is to help your body adjust, not to drive weight loss. Many people do notice something in this phase: food feels less urgent, portion sizes feel more manageable, the impulse to snack between meals quietly fades. That is GLP-1 receptor activation doing its early work. But the physical change on the scales is usually modest at this stage, and it is worth knowing that beforehand so you are not discouraged.

Nausea, indigestion and loose stools are common in the opening weeks, particularly around dose changes. These side effects are typically mild and settle within days rather than dragging on. The NHS semaglutide medicines page sets out what to expect and which symptoms warrant contacting a clinician. If you are curious about the biological reasons appetite shifts at all, the detail is covered in our guide to how Wegovy works.

So to answer the core question directly: Wegovy does start working almost immediately at a receptor level, but the effects most people care about (reduced hunger that persists, and actual weight change) take weeks to months to become obvious. The distinction matters.

Why does the dose schedule make immediate results unlikely?

Wegovy is prescribed in a step-up schedule: 0.25mg for four weeks, then 0.5mg, 1.0mg, 1.7mg, and finally 2.4mg maintenance, a process that takes roughly five months to complete. This is not bureaucracy; it is clinical design. Higher doses produce stronger appetite suppression, which is why the headline results from clinical trials come from the maintenance phase, not the first pen.

The STEP 1 trial (published in the New England Journal of Medicine) followed adults over 68 weeks and found an average weight reduction of around 15% at the 2.4mg dose alongside lifestyle changes. That figure represents nearly a year and a half of treatment, not a month. People who expect immediate dramatic results sometimes reduce the dose prematurely or stop altogether, right before the point where the medicine begins to work hardest. Staying with the titration plan your prescriber has set is the piece most people wish someone had told them earlier.

For a closer look at how the timeline plays out across different stages, when Wegovy starts working breaks it down by phase in more detail.

When should you expect to see noticeable weight loss?

Most people reach 5–10% body-weight loss somewhere between months two and five, depending on individual factors including starting weight, diet, activity and how they tolerate dose increases. The maintenance dose tends to be where weight loss accelerates most noticeably. If you want a sense of what that progression can look like in practice, our collection of Wegovy progress pics shows how results build across the different stages of treatment. Clinical trial participants continued to lose weight for the duration of the study, suggesting the medicine keeps working as long as it is taken, it is not a front-loaded effect.

NICE's recommendation for semaglutide, set out in TA875, includes a review point: if someone has not reached at least 5% weight loss after six months on the full maintenance dose, continuing should be assessed. That threshold gives you a practical way to evaluate progress with your prescriber rather than guessing.

Body composition changes (less visible fat around the abdomen, clothes fitting differently) often precede changes on the scales. People also describe shifts in their relationship with food that feel significant even before the numbers move much. Those early signals are real, even if they are not the 15% headline figure.

Does stopping Wegovy quickly reverse the effects?

Research suggests that much of the weight lost during Wegovy treatment returns within a year of stopping, which is why prescribers treat it as a long-term medicine rather than a short course. The appetite suppression is tied to the drug's presence; when semaglutide clears your system, hunger hormones rebound. That does not mean the medicine has failed, it reflects the biology of appetite regulation, not a flaw in the treatment.

It is also why decisions about stopping, pausing or switching should sit with your prescriber rather than being made independently. The semaglutide overview covers what the evidence says about long-term use, and if you want to understand how Wegovy compares at a mechanism level with other semaglutide-based options, how semaglutide works is a useful companion read.

If you have been considering starting treatment and want to understand the cost side, Wegovy pricing in the UK sets out what you should expect to pay through a legitimate private route. When you are ready to speak to a prescriber, check your eligibility with our clinical team, the consultation is free, and a real prescriber reviews your answers the same day.